This project was conducted through September, 2010 – September 2013 and was funded by a grant from the Agency for Healthcare Research and Quality. This large-scale multi-center project titled Blacks and Exacerbations on LABA v. Triotropium (BELT), a subcontract with Harvard University, was designed to compare the effectiveness of long-acting beta agonists (LABA)/inhaled corticosteroids (ICS) versus triotropium/ICS in African-American patients with moderate to severe asthma.
The specific aims of this project were to:
The primary outcome for this study was time to asthma exacerbation, defined as a worsening asthma event requiring oral or parenteral corticosteroids. Among black adults with asthma treated with ICS, adding a LABA did not improve time to asthma exacerbation compared with adding tiotropium. These findings were not affected by polymorphisms at the Arg16Gly locus of ADRB2. These findings do not support the superiority of LABA + ICS compared with tiotropium + ICS for black patients with asthma.
The asthma Symptom Free Days Questionnaire: how reliable are patient responses? Yawn BP, Israel E, Wechsler ME, Pace W, Madison S, Manning B, Doros G & Fuhlbrigge A (2018): Journal of Asthma.
Susceptibility to exacerbations in Black adults with asthma. Nicole L. Grossman, Gheorghe D. Doros, Nicolas Fandino, Anne L. Fuhlbrigge, Wilson D. Pace, Michael E. Wechsler, Barbara P. Yawn & Elliot Israel (2018), Journal of Asthma, DOI: 10.1080/02770903.2018.1486855
Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma. The BELT Randomized Clinical Trial. Wechsler ME, Yawn BP, Fuhlbrigge AL, Pace WD, Pencina MJ, Doros G, Kazani S, Raby BA, Lanzillotti J, Madinson S, Israel E. JAMA. 2015;314(16):1720-1730.
Brian Manning, MPH, CHES
Associate Research Director
AAFP National Research Network
1-800-274-2237, ext. 6151